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Abstract
BACKGROUND: The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a well-established instrument
used to evaluate the health status of heart failure (HF) patients. There has been a lack of clarity about the best
way to conceptualize the KCCQ. The purpose of this investigation of the KCCQ was to: (1) explore the factor
structure with an exploratory factor analyses; (2) perform reliability and validity testing to determine the best
factor solution for item groupings; and (3) determine the most meaningful components of health status
captured by the KCCQ.
METHODS AND RESULTS: A secondary analysis of data from 280 adults with stage-C HF enrolled from
three US northeastern sites was conducted to test the KCCQ subscale structure. Criterion-related validity for
the Self-efficacy subscale was tested with the Dutch Heart Failure Knowledge Scale and the Self-care of Heart
Failure Index Self-care Confidence Scale. Overall, internal consistency reliability (Cronbach's alpha) for the
KCCQ and subscales was 0.92, social interference (seven items, 0.90), physical limitation (four items, 0.84),
symptoms (eight items, 0.86), independent care (two items, 0.80), and self-efficacy (two items, 0.63). Two
items failed to correspond to a previously identified factor so the independent care subscale was added. Items
intending to measure quality of life were loaded in the social interference subscale.
CONCLUSIONS: We recommend eliminating the quality of life subscale and including those items in the
social interference subscale, and eliminating the self-efficacy items and re-evaluating the items related to
independent care.
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Psychometric properties of the Kansas City Cardiomyopathy 
Questionnaire (KCCQ)
Ruth Masterson Creber, Rosemary Polomano, John Farrar, and Barbara Riegel
University of Pennsylvania, Philadelphia, USA
Abstract
Background—The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a well-established 
instrument used to evaluate the health status of heart failure (HF) patients. There has been a lack 
of clarity about the best way to conceptualize the KCCQ. The purpose of this investigation of the 
KCCQ was to: (1) explore the factor structure with an exploratory factor analyses; (2) perform 
reliability and validity testing to determine the best factor solution for item groupings; and (3) 
determine the most meaningful components of health status captured by the KCCQ.
Methods and Results—A secondary analysis of data from 280 adults with stage-C HF enrolled 
from three US northeastern sites was conducted to test the KCCQ subscale structure. Criterion-
related validity for the Self-efficacy subscale was tested with the Dutch Heart Failure Knowledge 
Scale and the Self-care of Heart Failure Index Self-care Confidence Scale. Overall, internal 
consistency reliability (Cronbach’s alpha) for the KCCQ and subscales was 0.92, social 
interference (seven items, 0.90), physical limitation (four items, 0.84), symptoms (eight items, 
0.86), independent care (two items, 0.80), and self-efficacy (two items, 0.63). Two items failed to 
correspond to a previously identified factor so the independent care subscale was added. Items 
intending to measure quality of life were loaded in the social interference subscale.
Conclusions—We recommend eliminating the quality of life subscale and including those items 
in the social interference subscale, and eliminating the self-efficacy items and re-evaluating the 
items related to independent care.
Keywords
Factor analysis; health-related quality of life; health status; heart failure; psychometric testing; 
self-efficacy
Introduction
Heart failure (HF) is a common clinical syndrome characterized by progressive symptoms of 
fatigue, dyspnoea, oedema, cognitive impairment, decreased functional capacity, and 
difficulty performing activities of daily living.1 In the USA, the incidence of HF after 65 
years of age is about 10 per 1000 population,2 affecting nearly 6 million people. HF can 
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have a profound impact on all aspects of ‘progression, improve quality of life, relieve 
symptoms, and minimize negative consequences on physical and psychosocial well-
being’.3,4
It is critically important to assess patient-reported outcomes such as health status to gauge 
response to therapies instead of relying solely on assessments by health providers. The 
measurement of health status can be challenging due to variations in conceptual definitions 
and issues unique to specific health problems.5 The term health status has been used 
interchangeably with health-related quality of life (HRQoL), although others argue that they 
are distinct concepts.6–8 Providing definitional clarification is critical. Overall, health status 
includes measures of symptoms, functional limitations, and quality of life.9 Quality of life is 
closely related to health status, yet also distinct from it because it is influenced by a number 
of factors including but not limited to economic, political, spiritual, and cultural factors. 
HRQoL is a generic term typically used to encompass clinically relevant aspects of life 
including physical symptoms and effects of treatment, social wellbeing, and functionality in 
the sense of physical, emotional, cognitive, and sexual dimensions of life.5,8
A growing number of health status and HRQoL tools have been developed for populations 
with HF. Among these is the Kansas City Cardiomyopathy Questionnaire (KCCQ) a 
multidimensional scale, which has substantial clinical utility for measuring outcomes of HF 
over time. The original authors of the KCCQ use the terms health status and HRQoL 
interchangeably, and so these will also be applied in a similar context.9–11 Validity, 
reliability, and responsiveness of the KCCQ are well established, and yet there is a lack of 
clarity around the best way to conceptualize the KCCQ in terms of what it measures and the 
value of the subscales. Tests of construct validity for the KCCQ have shown strong 
associations with NYHA class, the Short Form (SF)-36 physical and social functioning 
domains, and the 6-minute walk test.10 Convergent validity exists for each of the five KCCQ 
subscales representing the intended conceptual domains.10 Moreover, acceptable reliability 
(e.g. internal consistency reliability with Cronbach’s alphas) and validity have been 
demonstrated for the KCCQ in HF populations with anaemia, heart transplantation, and a 
prior myocardial infarction.10–12 The KCCQ is versatile for culturally diverse patients. It has 
been translated into Swedish, Italian, German, Portuguese, Spanish, and Norwegian 
languages.12,13,14–17 Cross-cultural testing using both forward and backward validation 
techniques has been done.12–14
Though the KCCQ has been widely used, there are existing gaps in the literature including 
the following: an exploratory factor analysis has not been published and the original study 
explaining the development and evaluation of the tool was published more than 10 years 
ago.10 In this 10-year period, the clinical management and profile of HF patients has 
changed greatly. Therefore, in this study we re-examined the conceptual and item structure 
of the instrument as it was originally conceived using a diverse group of HF patients 
managed in the current era. The specific aims of this investigation were to: (1) explore the 
factor structure; (2) perform reliability and validity testing of the KCCQ; and (3) determine 
the most meaningful components of HRQoL captured by the KCCQ. This work has 
important implications for reconceptualizing KCCQ subscales and advancing its use in 
future studies of HF populations.
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Methods
Design and study procedures
A secondary data analysis was performed on the cross-sectional baseline data prospectively 
collected from a sample of 280 noninstitutionalized adults with HF who were prospectively 
enrolled from three outpatient settings in Philadelphia, Pennsylvania and Newark, Delaware 
between 2007 and 2009. Data were collected within a prospective cohort study examining 
the effect of excessive daytime sleepiness on HF self-care.18 Inclusion criteria specified 
enrolment of adults with chronic stage-C19 HF based on echocardiographic and clinical 
evidence. Potential subjects had to be fully capable of participating in the study so they were 
screened for visual acuity, hearing sufficient to engage in dialogue, and English literacy 
satisfactory for accurate completion of questionnaires. Cohorts with mild cognitive 
impairment were included by study design. At baseline, all participants completed the 
KCCQ, the Dutch Heart Failure Knowledge Scale, and the Self-care of Heart Failure Index 
(SCHFI) because a secondary aim was to establish the longitudinal relationships among 
excessive daytime sleepiness, HF self-care, and HRQoL. Knowledge was assumed to be 
required for HF self-care. Patients were excluded if they resided in a long-term care setting, 
worked nights or rotating shifts, had renal failure requiring dialysis, or if they had an 
imminently terminal illness, plans to move out of the area, history of serious drug or alcohol 
abuse within the past year, or major depressive illness. Research assistants collected data 
during home visits and clinical information was abstracted from the medical record by 
registered nurses. New York Heart Association (NYHA) functional class was obtained from 
a standardized interview,20 and then scored by a single board-certified cardiologist. 
Following enrolment and baseline evaluations, patients were followed up at 3 and 6 months. 
The complete study methodologies and procedures are reported elsewhere.18
Sample size calculation
Using an estimation of 10 observations per item as the minimum number for factor analysis 
techniques,21 at least 230 subjects were needed to establish construct validity of the KCCQ. 
Our sample of 280 subjects at baseline satisfied the requirement for an adequate sample size 
to evaluate the factor structure of the KCCQ.
Outcome measures
The KCCQ is a 23-item (15 question) self-administered questionnaire designed to quantify 
physical limitations, symptoms (frequency, severity and recent change over time), social 
limitations, self-efficacy, and quality of life.10 All items are measured on a Likert scale with 
5–7 response options. There are five individual subscales, and all, except the Self-efficacy 
subscale, are aggregated into clinical and overall summary scores. Scores for each subscale 
are standardized to range from 0 to 100 with higher scores indicating better health status, 
fewer symptoms, and greater disease-specific HRQoL.11
The SCHFI version 6.2 is a 22-item, self-reported, HF-specific tool designed to quantify 
self-care maintenance, self-care management, and self-care confidence.22 Only the Self-care 
Confidence Scale was used in this analysis. In this sample, the internal consistency was 0.84 
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for self-care confidence, which is consistent with that reported by the instrument author 
(0.83).22
The Dutch Heart Failure Knowledge Scale is a 15-item multiple choice, self-administered 
questionnaire that measures HF knowledge in general, knowledge of HF treatment, and HF 
symptoms and recognition.23 The scale has a maximum summary score of 15 (indicating 
optimal knowledge) and a minimum score of 0 (indicating no knowledge). The published 
reliability of the instrument has a Cronbach’s alpha of 0.62.23 According to Nunnally and 
Bernstein,24 0.7 is an acceptable score for overall reliability; however, lower thresholds are 
sometimes used in the literature. The content of the questionnaire underwent face validation 
by 10 HF nurses from the Dutch Society of Cardiovascular Nursing, two cardiologists and 
six patients. For construct validation, the authors used a known groups technique, comparing 
people who were newly diagnosed with HF and had received no education and patients who 
had already received comprehensive education. There was a statistically significant 
(p<0.0001) difference in mean Dutch Heart Failure Knowledge Scale scores between these 
two groups.23
Statistical analysis
Baseline sample characteristics are reported using frequencies, percentages for categorical 
variables, and means and standard deviations for continuous variables. The distribution of 
patient responses to the KCCQ was examined, including the frequency and means and 
standard deviations. Psychometric analyses used to evaluate the KCCQ were consistent with 
traditional psychometric methods described by Nunnally and Bernstein,24 and included both 
measures of internal consistency reliability (Cronbach’s alpha) and construct and criterion-
related validity. Correlation statistics were used to examine relationships among variables, 
and Student’s t-tests for independent groups to detect between group differences. All 
analytical procedures were performed using SPSS version 17.0 for Windows (SPSS, 
Chicago, IL, USA).
Psychometric testing
Criterion-related validity—Criterion-related validity of the KCCQ Self-efficacy subscale 
was assessed by examining bivariate correlations with both the SCHFI Self-care Confidence 
Scale and the Dutch Heart Failure Knowledge scale. The KCCQ Self-efficacy subscale was 
validated against the Dutch Heart Failure Knowledge Scale because the two KCCQ Self-
efficacy subscale items ask pragmatic HF knowledge questions. Conceptually, self-care 
confidence is closely related with self-efficacy, which is why the Self-efficacy subscale was 
validated against the SCHFI Self-care Confidence Scale.
Construct validity—For construct validity, exploratory principal components factor 
analyses with orthogonal and oblique rotations established the basis for a covariance matrix 
to examine item groupings. Both varimax (orthogonal assuming independence of factors) 
and promax (oblique presupposing correlation among two or more factors) rotations were 
done to determine the best factor structure.25 Criteria for examining the factor structure and 
assignment of items to factors included Eigen values >1, a scree plot to visualize in 
descending order of magnitude of Eigen values from the correlation matrix, and factor 
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loading coefficients >0.40 for individual items from the principal component exploratory 
factor analysis. The best factor solution was determined by the intuitive relevance of the 
item within the subscale, retention of item groupings from the original KCCQ version, and 
Cronbach’s alpha values for each factor structure with and without the item. The factor 
analysis was performed on data obtained at baseline.
Once the factor structure was identified, subscale scores were calculated and transformed to 
a scale of 0 to 100 (highest level of functioning) using standard procedures described by 
Green et al.10 The item scores for a given subscale were summed, then the lowest possible 
score for the scale was subtracted from the scale sum (each item’s lowest score was 1). The 
total value was divided by the range for the subscale and multiplied by 100. Cases that had 
missing data for any of the subscale items were not transformed into a score for that 
respective subscale.
Reliability—Internal consistency reliability for the instrument and subscales was measured 
by Cronbach’s alpha values. Item analyses were performed considering item-to-item 
intercorrelations, item-to-subscale correlations, and internal consistency reliability 
(Cronbach’s alpha) with item deletion. Cronbach’s alpha values >0.70 were considered 
acceptable, above 0.80 good, and above 0.90 excellent.24
Consistent with Green and colleagues’10 approach to establishing test–retest reliability for 
the stability of performance, paired t-tests were used to compare mean scores for each of the 
subscales using study data from baseline and 6 month data collection points. Mean 
differences in subscale scores between time points were also obtained. Intraclass correlation 
(ICC) was used as a measure of stability by Ortega et al.,15 and so ICC coefficients were 
calculated for each subscale as an indicator of a subscale’s measurement stability using 
baseline and 6 month data.
Results
Demographic and clinical characteristics
Data related to sample characteristics (n=280) are reported in Table 1. The mean age of 
respondents was 61.9±12.5 years and 64% were male. Thirty-seven per cent had an 
ischaemic HF aetiology, and 77% were diagnosed with NYHA class III or IV HF. The 
majority (81%) lived with a partner. Minority racial groups represented 37% of the sample, 
and 54% had at least some college education.
Exploratory factor analyses
Both principal component varimax and promax rotations were performed on all baseline 
data for the 23-item KCCQ. Presupposing correlations among two or more factors with the 
promax rotation factor structure (oblique rotation) yielded higher factor loadings and a more 
interpretable factor structure. This factor structure was more similar to the original KCCQ 
item groupings when compared to the varimax rotation method, which assumed 
independence of factors. The principal component promax factor analysis confirmed a five-
factor solution with Eigen values >1, which explained 67.2% of the variance in the measure. 
Factor loading coefficients were examined to determine the placement of items on factors, 
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and coefficients >0.4 were considered acceptable to retain in an item grouping. High factor 
loadings >0.7 existed for all but five items, which loaded on their respective factors with 
lower coefficients (Table 2).
The factor structure from this analysis includes five subscales, consistent with the original 
factor structure. However, compared to the original publication, five items loaded differently 
across three subscales. No items loaded on the Quality of Life subscale. Instead, the items 
intended to measure quality of life in the original questionnaire (items 17–19) loaded on 
Social Interference with loading coefficients >0.76. In the interpretation of the factor 
analysis, the Quality of Life subscale was eliminated because no items loaded on a single 
factor representative of this overall domain. The two items for Quality of Life in the original 
version demonstrated higher factor loadings on the Social Interference subscale, and when 
evaluating their relevance to this domain it was intuitively a good fit. The two Self-efficacy 
items (15 and 16) loaded with high factor coefficients >0.84 in the Self-efficacy subscale, 
yet the items themselves were not consistent with the concept of self-efficacy. Conceptual 
clarity around self-efficacy is addressed later in the discussion. Two items (1 and 2) intended 
to measure physical limitations had high factor loadings (>0.83) on a separate, previously 
undefined, subscale. These items pertained to dressing and bathing, and the new subscale 
was named Independent Care.
Table 2 indicates the discrepancies between the original version where items were classified 
by author consensus and the results of our exploratory factor analysis. To reconcile 
differences from the original version to the new factor structure, changes to the KCCQ 
included: (1) a new subscale for Independent Care (items 1 and 2); (2) elimination of the 
Quality of Life subscale; and (3) integration of the two previous items in this subscale into 
the Social Interference subscale.
To explore relationships among the newly formed subscales, an intercorrelation matrix of 
the KCCQ was completed. The subscale Social Interference (items 17–23) was highly 
correlated with Physical Limitations (items 3–6) (r=0.683, p<0.001) and Symptoms (items 
7–14) (r=0.742, p<0.001). A moderate correlation existed (r=0.417, p<0.001) between 
Independent Care (items 1–2) and Physical Limitations (items 3–6). This was an expected 
finding because the Independent Care items were originally designed to fit in the Physical 
Limitations subscale. Correlation coefficients less than 0.415 were found between 
Independent Care and all the other subscales. The Self-efficacy subscale (items 15 and 16) 
had very low correlations (r<0.23) with all other subscales, revealing the independent nature 
of these two items.
Reliability and item analysis
Overall internal consistency reliability (Cronbach’s alpha) for all items in the KCCQ was 
0.92 for the baseline data and 0.928 for data obtained at 6 months. Table 3 shows the item-
to-total correlations and changes in overall Cronbach’s alpha with each item deleted from 
the questionnaire. The weakest correlations were noted for the two Self-efficacy items (15 
and 16; r=0.184 and 0.189, respectively. If they were deleted, the overall Cronbach’s alpha 
would increase to 0.93. Cronbach’s alpha values for each of the new subscale configurations 
were ≥0.80 for all subscales at both baseline and 6 months with the exception of Self-
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efficacy (Table 3). Self-efficacy was 0.626 and 0.608, respectively, for the two time points. 
Again, Nunnally and Bernstein24 has established 0.7 as an acceptable level for overall 
reliability; however, lower thresholds are accepted, especially for subscales with fewer 
items.
The results for test–retest reliability, including mean subscale scores, paired t-test p-values, 
and ICC using the one-way method and average measures coefficient are reported in Table 
4. There was a statistically significant difference between the baseline and 6-month mean 
subscale scores for only Social Interference (p=0.005) meaning that there was significant 
improvement, albeit small (a mean difference of 4.23 points, 0–100) over the 6 months in 
this relatively stable cohort of patients. ICC coefficients for the Social Interference, Physical 
Limitations, and Symptoms subscales all demonstrated high test–retest reliability (≥0.81), 
and Self-efficacy was 0.66, indicating moderate test–retest reliability. The ICC coefficient 
for Independent Care, however, was lower at 0.47 and this may be indicative that 
perceptions of the ability to perform self-care behaviours may not be as stable in patients 
with NYHA functional class III and IV or even as relevant to their overall health status.
Additional tests for validity
Concurrent validity for the Self-efficacy subscale was assessed by examining the strength of 
the relationship between the KCCQ Self-efficacy subscale and SCHFI Self-care Confidence 
Scale. Using Cohen’s guide for social phenomena to classify the effect size,26 a moderate 
correlation was found (r=0.40, p<0.001) between the KCCQ Self-efficacy subscale and the 
SCHFI Self-care Confidence Scale. Further analyses sought to establish a relation between a 
self-efficacy and knowledge because the self-efficacy questions relate to knowledge of HF. 
The correlation between the KCCQ Self-efficacy subscale and the Dutch Heart Failure 
Knowledge score was weak, and not statistically significant (r=0.115, p=0.06).
Discussion
This analysis provides concrete suggestions for how the KCCQ can be improved to meet the 
needs and profile of current HF patients. Our investigation verifies the reliability and 
supports a related but different factor structure for the KCCQ. While the KCCQ is a reliable 
and valid outcomes measurement tool for assessing HRQoL or health status in HF patients, 
our analysis raises questions about the component factors and questions the general 
usefulness of the Self-efficacy and Quality of Life subscales.
In terms of internal consistency reliability, the analyses for both the overall questionnaire 
and the subscales, yielded acceptable Cronbach’s alphas. Table 4 shows that there was 
minimal change in the mean subscale values from baseline to 6 months, demonstrating test–
retest reliability. This was expected because the population consisted of stable stage-C HF 
patients maintained on medical therapy with no intervention implemented as part of the 
study. ICC coefficients based on baseline and 6 month data were also acceptable in 
demonstrating test–retest reliability, except for the new Independent Care subscale. In fact, 
coefficients for the Social Interference, Physical Limitations, and Symptoms subscales, all 
above (space) 0.8.80, were similar to those reported by Ortega et al.15 who studied a 
population (n=186) with a significant portion of the sample classified as NYHA functional 
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class I and II. The relative importance of the Independent Care items will need to be further 
evaluated in subsequent studies.
The results of this study are consistent with seven published studies since 2000 that 
conducted KCCQ psychometric analyses with different patient populations from the 
following countries: USA, Portugal, Germany, Italy, Spain, Sweden, and Norway.10,13–16 
All of these investigations reported Cronbach’s alpha scores greater than 0.70 for Physical 
Limitations, Symptoms, and Social Interference. The lowest Cronbach’s alpha scores across 
all studies were for the Self-efficacy subscale, which ranged from 0.46–0.67.
Since the original publication by Green et al.,10 there has been growing consensus that the 
KCCQ subscales fit best in four rather than five subscales. In a publication of a 
psychometric analysis of anaemic and non-anaemic HF patients, Spertus et al.11 reported 
that the KCCQ has four subscales including: (1) Physical Limitations; (2) Symptoms 
(frequency, severity, and change over time); (3) Quality of Life/perception of social 
interference due to heart failure; and (4) Self-efficacy. Consistent with this finding, Ortega et 
al.15 found that the Quality of Life items loaded on Social Interference rather than a separate 
Quality of Life subscale. Our results suggest that the items intended to measure quality of 
life be reclassified under the Social Interference subscale. As such, we also recommend 
eliminating the Quality of Life subscale because the items are a poor measure of global 
quality of life, and the subscale is redundant in a HRQoL tool.
Limitations
A limitation of this exploratory factor analysis is that the results could be due to differences 
between the original sample population and the one reported here. However, our sample 
demographics were similar to the population in the original validation study of the KCCQ 
by Green et al.10 in terms of mean age, 61.9 years and 64.3 years and male gender, 64% and 
70%, in this and the previous study, respectively. The mean per cent ejection fraction (EF) 
for our sample was higher than the previous study sample (23.5% compared to 35.4%). We 
attribute this difference to our inclusion of systolic, diastolic, and mixed HF patients. Other 
than specifying that patients had a diagnosis of HF and EF <40%, Green et al. did not further 
specify the aetiology of HF in either the stable reliability cohort or less stable responsiveness 
cohort.10 With similar sample demographics, the results from this study cannot solely be 
explained by differences in the sample populations.
Another limitation with this factor analysis was that it was performed on a single sample of 
cross-sectional data. Before consideration for revision of this questionnaire, these results 
should be confirmed in other patient populations, including testing the tool in a more 
progressively debilitated or unstable cohort to observe for uniformity in the strength of 
factor loadings across the new factor structure.
Conclusions
Based on the psychometric evaluation results, we recommend that items 1 and 2 related to 
limitations from shortness of breath and fatigue while dressing, showering, and bathing 
receive further consideration and potentially be considered for deletion. These items may not 
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have loaded with the other physical limitations because they are relatively uncommon for 
people with HF.
We found only a moderate relationship between the KCCQ Self-efficacy subscale and the 
SCHFI Self-care Confidence Scale. A strong correlation was not anticipated considering that 
the KCCQ Self-efficacy subscale measures a respondent’s knowledge of disease,13 rather 
than the operational understanding of self-efficacy, which is an individual’s level of 
confidence in his/her ability to successfully attain specific goals despite known barriers.27 
The magnitude of this correlation might be explained by the likelihood that these two 
concepts, while distinct, co-vary in the context of experiences with HF. There was a weak 
correlation between the KCCQ Self-efficacy subscale and the Dutch Heart Failure 
Knowledge score. This finding was not expected because both the Dutch Knowledge score 
and KCCQ self-efficacy items (15 and 16) address aspects of symptom recognition. Though 
both instruments address symptom recognition, the KCCQ self-efficacy items relate more to 
responding to symptom changes, whereas the Dutch Knowledge score integrates a holistic 
understanding of general and specific HF knowledge about treatment, symptoms, and 
symptom recognition.23
The measurement of self-efficacy is important because it is a good predictor of functional 
capacity in terms of behaviour, persistence, thoughts, and emotional reactions.28–30 Self-
efficacy is influenced by both internal and external environmental factors and is based on 
four sources of information: performance accomplishments, vicarious experience, verbal 
persuasion, and physiological information.31 It is also essential to measure self-efficacy 
across multiple circumstances and disease trajectories to capture the full scope of a person’s 
ability to persist despite setbacks and to self-evaluate their capacity to achieve a goal.30,32,33
The original concept for the Self-efficacy subscale was based on the hypothesis that patients 
with HF exacerbations are less knowledgeable about disease management than stable 
outpatients,10 and thus at risk for poorer outcomes. While there is agreement that measuring 
patients’ knowledge about how to manage their disease is of value, the items in the KCCQ 
Self-efficacy subscale are not consistent with the theoretical concept of self-efficacy and 
therefore are not representative of the concept. Further, we propose a revision to the 
questionnaire’s factor structure that is based on an exploratory factor analysis from a sample 
of NYHA class III and IV HF patients with relatively stable disease receiving medical 
management. It will be important for replication studies to confirm this factor structure in 
other HF populations and intervention-based research.
Few instruments are available to accurately measure self-efficacy in HF patients. While the 
KCCQ is purported to capture the domain of self-efficacy, this assumption remains 
questionable. Researchers interested in aspects of self-efficacy as a means to profile this 
concept in HF patients or as a determinant of therapeutic interventions should strongly 
consider a more robust measure representing the complexity of conceptual features of self-
efficacy. The KCCQ could be improved by deleting the Self-efficacy subscale, renaming the 
subscale to be more consistent with the nature of the items or redesigning self-efficacy items 
in ways that are aligned with more current conceptualization of the domain. Any one of 
these options would not substantially alter the instrument as the Self-efficacy subscale is not 
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factored into either the functional or clinical summary score. The functional score combines 
the Physical Limitation and Symptom subscales and the clinical score combines the 
functional status summary score with the Quality of Life and Social Limitation subscales.10 
Because prior research using the KCCQ relies on the numerous composite subscale and 
summary scores, it would still be possible to derive meaningful comparisons across studies 
even if the Self-efficacy subscale was modified or eliminated.
Nonetheless, the KCCQ is one of the most comprehensive, useful, and valid disease-specific 
HRQoL instrument for measuring the health status of patients with HF. Across all items, 
there is congruence with various aspects of HRQoL in HF patients. Specifically the 
dimensions of social interference, physical limitations, and disease symptoms characterize 
perceptions and experiences unique to stable and progressive presentations of HF. There is 
no dispute regarding its value and accuracy in gaining a broader understanding of HF-
specific health status. As with all patient-reported outcomes, it is necessary to subject 
instruments to ongoing psychometric testing in ways that will uncover opportunities to 
improve their reliability, validity, responsiveness, and utility. In moving forward, the authors 
plan to collaborate with the developers of the KCCQ to establish the basis for further 
confirming a new factor structure that better accommodates items representing conceptual 
domains. With now more than 10 years since the original publication of the KCCQ, perhaps 
it is the time to reconceptualize certain aspects of the instrument and publish an updated 
version.
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Table 1
Demographic, clinical, and treatment characteristics of the sample of adults with heart failure participating in 
the psychometric evaluation of the Kansas City Cardiomyopathy Questionnaire
Variables Total (n) Sample
Age (years) 280 61.9±12.5
Ejection fraction 279 35.4±17.0
Gender
  Male 180 64
  Female 100 36
Marital status
  Married or living with a partner 226 81
  Single 54 19
Race
  Black 96 34
  White 175 63
  Other 9 3
Education
  < High school 27 10
  High school 102 36
  At least some college 151 54
Income
  More than needed 98 35
  Enough to meet needs 137 49
  Less than needed 45 16
Heart failure type
  Systolic 194 69
  Diastolic 53 19
  Mixed 32 11
  Unspecified 1 0
Heart failure aetiologya
  Ischaemic 102 37
  Nonischaemic 177 63
NYHA functional class
  I 12 4
  II 54 19
  III 164 59
  IV 50 18
Values are mean±SD or %.
a
Indicates missing data.
NYHA, New York Heart Association.
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Table 3
Subscale item-to-total correlations and Cronbach’s alpha
Subscale 
mean if
item deleted
Scale 
variance if
item deleted
Corrected item–
total correlation
Cronbach’s 
alpha
if item deleted
Social Interference
17. How much has your HF limited your enjoyment of life? 89.78 349.69 0.750 0.923
18. If you had to spend the rest of your life with 90.30 348.61 0.649 0.924
HF as it is now, how would you feel about this?
19. How often have you felt discouraged because of your HF? 89.73 360.63 0.602 0.926
20. How much does HF affect your … hobbies, recreational 
activities
89.86 344.40 0.669 0.924
21. Working or doing household chores 90.03 341.82 0.775 0.922
22. Visiting family or friends out your home 89.34 347.91 0.734 0.923
23. Intimate relationships with loved ones 89.51 348.52 0.554 0.926
Physical Limitations
  3. Walking 1 block on level ground 89.55 349.90 0.616 0.925
  4. Doing yard work, housework or carrying groceries 90.10 346.66 0.674 0.924
  5. Climbing a flight of stairs without stopping 90.03 342.07 0.706 0.923
  6. Hurrying or jogging (as if to catch a bus) 90.69 341.75 0.587 0.926
Symptoms
  7. My symptoms have changed over 2 weeks 89.73 359.46 0.459 0.928
  8. How many times did you have swelling in your feet, ankles or 
legs when you woke up in the morning
89.24 368.83 0.349 0.929
  9. How much has swelling in your feet, ankles or legs bothered 
you?
88.54 359.59 0.464 0.928
  10. How many times has fatigue limited your ability to do what 
you want?
88.78 334.69 0.694 0.924
  11. How much has your fatigue bothered you? 89.85 343.49 0.697 0.923
  12. How many times has SOB limited your ability to do what you 
wanted?
88.48 326.87 0.780 0.922
  13. How much has your SOB bothered you? 89.51 341.81 0.731 0.923
  14. How many times have you been forced to sleep sitting up in a 
chair with at least 3 pillows because of SOB?
89.18 359.78 0.467 0.927
Independent Care
  1. Dressing yourself 88.89 369.57 0.433 0.928
  2. Showering/bathing 88.83 373.26 0.338 0.929
Self-efficacy
15. How sure are you that you know what to do, or whom to call, if 
your HF gets worse?
89.10 377.03 0.184 0.931
16. How well do you understand what things you are able to do to 
keep your HF from getting worse?
89.00 379.13 0.189 0.930
SOB, shortness of breath.
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Table 4
KCCQ test–retest reliability using paired t-test and intraclass correlation (ICC) coefficient
Means ICC
Baseline 6 month Difference (6 month–baseline) p-valuea
Social Interference 65.25 69.48 4.23 0.005 0.82
Physical Limitations 60.54 61.84 1.30 0.427 0.85
Symptoms 68.69 70.57 1.87 0.066 0.81
Independent Care 92.31 92.70 0.39 0.783 0.47
Self-efficacy 88.43 90.29 1.86 0.056 0.66
a
Two-tailed p-value is baseline vs. 6 months.
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